Purine

Purine

SCHEMBL3021752

CN.c1ncc2nc[nH]c2n1

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4A O75164 1/20 0.36
KDM4B O94953 1/20 0.36
KDM5C P41229 1/20 0.36
KDM4C Q9H3R0 1/20 0.36
KDM5B Q9UGL1 1/20 0.36
KDM3A Q9Y4C1 1/20 0.36
KDM4E B2RXH2 4/20 0.34
ALDH1A1 P00352 4/20 0.34
TDP1 Q9NUW8 2/20 0.34
HPGD P15428 2/20 0.34
TP53 P04637 1/20 0.34
PTGS1 P23219 1/20 0.34
HBB P68871 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MAPT P10636 2/20 0.33
APEX1 P27695 1/20 0.33
RECQL P46063 1/20 0.33
BLM P54132 1/20 0.33
BTK Q06187 1/20 0.32
EGFR P00533 5/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Purine SCHEMBL2120547 0.96 KDM4A (0.38) KDM4AKDM4BKDM5CKDM4CKDM5B
Purine SCHEMBL3157 0.96
Purine SCHEMBL29456595 0.96
Purine SCHEMBL6421376 0.96 KDM4A (0.38) KDM4AKDM4BKDM5CKDM4CKDM5B
Purine SCHEMBL311318 0.93 KDM4A (0.37) KDM4AKDM4BKDM5CKDM4CKDM5B
Purine SCHEMBL6438162 0.93 KDM4A (0.37) KDM4AKDM4BKDM5CKDM4CKDM5B
Purine SCHEMBL5611476 0.93 KDM4A (0.37) KDM4AKDM4BKDM5CKDM4CKDM5B
Purine SCHEMBL1150716 0.93 KDM4A (0.37) KDM4AKDM4BKDM5CKDM4CKDM5B
Purine SCHEMBL37119 0.93 KDM4A (0.37) KDM4AKDM4BKDM5CKDM4CKDM5B
Purine SCHEMBL9057416 0.93 KDM4A (0.37) KDM4AKDM4BKDM5CKDM4CKDM5B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100204187-A1 Purine Derivatives PALAU PHARMA, S.A. (ES) 2010-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100204187-A1 Purine Derivatives JAK3, JAK1, JAK2 KDM4A 2009/4885KDM4B 2310/4885KDM5C 1987/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.